Sabra Healthcare REIT, Inc. $SBRA Shares Sold by SG Americas Securities LLC

SG Americas Securities LLC lowered its stake in Sabra Healthcare REIT, Inc. (NASDAQ:SBRA) by 91.8% during the third quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 35,585 shares of the real estate investment trust’s stock after selling 398,833 shares during the quarter. SG Americas Securities LLC’s holdings in Sabra Healthcare REIT were worth $663,000 as of its most recent filing with the SEC.

Several other hedge funds also recently bought and sold shares of SBRA. Hennion & Walsh Asset Management Inc. purchased a new stake in shares of Sabra Healthcare REIT in the third quarter valued at $473,000. Asset Management One Co. Ltd. raised its stake in Sabra Healthcare REIT by 6.2% in the 3rd quarter. Asset Management One Co. Ltd. now owns 498,529 shares of the real estate investment trust’s stock valued at $9,293,000 after purchasing an additional 29,019 shares during the last quarter. VIRGINIA RETIREMENT SYSTEMS ET Al lifted its holdings in Sabra Healthcare REIT by 51.2% in the 3rd quarter. VIRGINIA RETIREMENT SYSTEMS ET Al now owns 577,800 shares of the real estate investment trust’s stock valued at $10,770,000 after purchasing an additional 195,600 shares in the last quarter. CWM LLC lifted its holdings in Sabra Healthcare REIT by 71.8% in the 3rd quarter. CWM LLC now owns 27,401 shares of the real estate investment trust’s stock valued at $511,000 after purchasing an additional 11,456 shares in the last quarter. Finally, Pacer Advisors Inc. boosted its stake in shares of Sabra Healthcare REIT by 581.4% during the 3rd quarter. Pacer Advisors Inc. now owns 51,254 shares of the real estate investment trust’s stock worth $955,000 after purchasing an additional 43,732 shares during the last quarter. Hedge funds and other institutional investors own 99.40% of the company’s stock.

Sabra Healthcare REIT Trading Up 0.5%

NASDAQ SBRA opened at $19.31 on Thursday. The company’s fifty day simple moving average is $19.04 and its 200-day simple moving average is $18.69. Sabra Healthcare REIT, Inc. has a 52 week low of $15.60 and a 52 week high of $19.97. The company has a current ratio of 5.19, a quick ratio of 5.19 and a debt-to-equity ratio of 0.92. The stock has a market cap of $4.81 billion, a P/E ratio of 26.82, a PEG ratio of 1.17 and a beta of 0.67.

Sabra Healthcare REIT (NASDAQ:SBRA) last released its quarterly earnings results on Wednesday, November 5th. The real estate investment trust reported $0.38 earnings per share for the quarter, beating analysts’ consensus estimates of $0.37 by $0.01. Sabra Healthcare REIT had a net margin of 23.50% and a return on equity of 6.38%. The business had revenue of $190.04 million during the quarter, compared to analyst estimates of $193.44 million. During the same period last year, the business earned $0.37 EPS. The business’s revenue was up 6.7% on a year-over-year basis. Sabra Healthcare REIT has set its FY 2025 guidance at 1.455-1.465 EPS. Equities research analysts predict that Sabra Healthcare REIT, Inc. will post 1.45 EPS for the current fiscal year.

Sabra Healthcare REIT Dividend Announcement

The firm also recently disclosed a quarterly dividend, which was paid on Friday, November 28th. Shareholders of record on Monday, November 17th were paid a dividend of $0.30 per share. This represents a $1.20 dividend on an annualized basis and a yield of 6.2%. The ex-dividend date was Monday, November 17th. Sabra Healthcare REIT’s dividend payout ratio (DPR) is 166.67%.

Wall Street Analyst Weigh In

A number of research firms have recently weighed in on SBRA. Cantor Fitzgerald initiated coverage on shares of Sabra Healthcare REIT in a research report on Wednesday, October 1st. They issued a “neutral” rating and a $20.00 price objective for the company. Wells Fargo & Company boosted their price target on Sabra Healthcare REIT from $20.00 to $21.00 and gave the company an “overweight” rating in a report on Tuesday, November 25th. Wall Street Zen raised Sabra Healthcare REIT from a “sell” rating to a “hold” rating in a research note on Saturday, January 3rd. Weiss Ratings restated a “buy (b)” rating on shares of Sabra Healthcare REIT in a report on Wednesday, October 8th. Finally, National Bankshares set a $22.00 target price on Sabra Healthcare REIT in a research note on Friday, October 17th. Four research analysts have rated the stock with a Buy rating and five have issued a Hold rating to the company. According to data from MarketBeat, the company presently has an average rating of “Hold” and an average target price of $21.11.

Sabra Healthcare REIT Company Profile

Sabra Healthcare REIT, Inc (NASDAQ: SBRA) is a real estate investment trust that acquires, owns and operates net‐lease healthcare properties. Its diversified portfolio spans senior housing communities, skilled nursing and rehabilitation centers, outpatient medical facilities, medical office buildings, hospitals and life science properties. Sabra structures long‐term, triple‐net lease agreements with healthcare operators, providing stable rental income streams while allowing tenants to focus on patient care and operational excellence.

Serving a broad spectrum of care segments, Sabra’s tenants include both regional and national providers of assisted living, independent living, memory care, post‐acute rehabilitation and research and development laboratories.